Cargando…
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas
BACKGROUND: Advanced therapies using adult mesenchymal stromal cells (MSCs) for neurodegenerative diseases are not effectively translated into the clinic. The cross talk between the transplanted cells and the host tissue is something that, despite its importance, is not being systematically investig...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392272/ https://www.ncbi.nlm.nih.gov/pubmed/35987845 http://dx.doi.org/10.1186/s13287-022-03129-y |
_version_ | 1784771026271338496 |
---|---|
author | Norte-Muñoz, María Gallego-Ortega, Alejandro Lucas-Ruiz, Fernando González-Riquelme, María J. Changa-Espinoza, Yazmín I. Galindo-Romero, Caridad Ponsaerts, Peter Vidal-Sanz, Manuel García-Bernal, David Agudo-Barriuso, Marta |
author_facet | Norte-Muñoz, María Gallego-Ortega, Alejandro Lucas-Ruiz, Fernando González-Riquelme, María J. Changa-Espinoza, Yazmín I. Galindo-Romero, Caridad Ponsaerts, Peter Vidal-Sanz, Manuel García-Bernal, David Agudo-Barriuso, Marta |
author_sort | Norte-Muñoz, María |
collection | PubMed |
description | BACKGROUND: Advanced therapies using adult mesenchymal stromal cells (MSCs) for neurodegenerative diseases are not effectively translated into the clinic. The cross talk between the transplanted cells and the host tissue is something that, despite its importance, is not being systematically investigated. METHODS: We have compared the response of the mouse healthy retina to the intravitreal transplantation of MSCs derived from the bone marrow in four modalities: syngeneic, allogeneic, xenogeneic and allogeneic with immunosuppression using functional analysis in vivo and histology, cytometry and protein measurement post-mortem. Data were considered significant (p < 0.05) after nonparametric suitable statistical tests. RESULTS: Transplanted cells remain in the vitreous and are cleared by microglial cells a process that is quicker in allotransplants regardless of immunosuppression. All transplants cause anatomical remodelling which is more severe after xenotransplants. Xeno- and allotransplants with or without immunosuppression cause macro- and microglial activation and retinal functional impairment, being xenotransplants the most detrimental and the only ones that recruit CD45(+)Iba1(−)cells. The profile of proinflammatory cytokines changes in all transplantation settings. However, none of these changes affect the retinal ganglion cell population. CONCLUSIONS: We show here a specific functional and anatomical retinal response depending on the MSC transplantation modality, an aspect that should be taken into consideration when conducting preclinical studies if we intend a more realistic translation into clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03129-y. |
format | Online Article Text |
id | pubmed-9392272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93922722022-08-21 Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas Norte-Muñoz, María Gallego-Ortega, Alejandro Lucas-Ruiz, Fernando González-Riquelme, María J. Changa-Espinoza, Yazmín I. Galindo-Romero, Caridad Ponsaerts, Peter Vidal-Sanz, Manuel García-Bernal, David Agudo-Barriuso, Marta Stem Cell Res Ther Research BACKGROUND: Advanced therapies using adult mesenchymal stromal cells (MSCs) for neurodegenerative diseases are not effectively translated into the clinic. The cross talk between the transplanted cells and the host tissue is something that, despite its importance, is not being systematically investigated. METHODS: We have compared the response of the mouse healthy retina to the intravitreal transplantation of MSCs derived from the bone marrow in four modalities: syngeneic, allogeneic, xenogeneic and allogeneic with immunosuppression using functional analysis in vivo and histology, cytometry and protein measurement post-mortem. Data were considered significant (p < 0.05) after nonparametric suitable statistical tests. RESULTS: Transplanted cells remain in the vitreous and are cleared by microglial cells a process that is quicker in allotransplants regardless of immunosuppression. All transplants cause anatomical remodelling which is more severe after xenotransplants. Xeno- and allotransplants with or without immunosuppression cause macro- and microglial activation and retinal functional impairment, being xenotransplants the most detrimental and the only ones that recruit CD45(+)Iba1(−)cells. The profile of proinflammatory cytokines changes in all transplantation settings. However, none of these changes affect the retinal ganglion cell population. CONCLUSIONS: We show here a specific functional and anatomical retinal response depending on the MSC transplantation modality, an aspect that should be taken into consideration when conducting preclinical studies if we intend a more realistic translation into clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03129-y. BioMed Central 2022-08-20 /pmc/articles/PMC9392272/ /pubmed/35987845 http://dx.doi.org/10.1186/s13287-022-03129-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Norte-Muñoz, María Gallego-Ortega, Alejandro Lucas-Ruiz, Fernando González-Riquelme, María J. Changa-Espinoza, Yazmín I. Galindo-Romero, Caridad Ponsaerts, Peter Vidal-Sanz, Manuel García-Bernal, David Agudo-Barriuso, Marta Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title | Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title_full | Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title_fullStr | Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title_full_unstemmed | Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title_short | Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
title_sort | immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392272/ https://www.ncbi.nlm.nih.gov/pubmed/35987845 http://dx.doi.org/10.1186/s13287-022-03129-y |
work_keys_str_mv | AT nortemunozmaria immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT gallegoortegaalejandro immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT lucasruizfernando immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT gonzalezriquelmemariaj immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT changaespinozayazmini immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT galindoromerocaridad immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT ponsaertspeter immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT vidalsanzmanuel immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT garciabernaldavid immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas AT agudobarriusomarta immunerecognitionofsyngeneicallogeneicandxenogeneicstromalcelltransplantsinhealthyretinas |